ClinicalTrials.govpublic full text
Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
multiple myeloma, relapsed or refractory multiple myeloma, rrmm, bortezomib, dexamethasone, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 888600
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.